首页> 美国卫生研究院文献>Medical Mycology Case Reports >Sporotrichosis by Sporothrix schenckii senso stricto with itraconazole resistance and terbinafine sensitivity observed in vitro and in vivo: Case report
【2h】

Sporotrichosis by Sporothrix schenckii senso stricto with itraconazole resistance and terbinafine sensitivity observed in vitro and in vivo: Case report

机译:在体外和体内观察到的Sporothrix schenckii senso stricto的孢子菌病具有伊曲康唑抗性和特比萘芬敏感性:病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report a case of a patient with lymphocutaneous sporotrichosis in the right upper limb. The fungus was identified as Sporothrix schenckii senso stricto by calmodulin gene sequencing. The initial treatment was itraconazole (200 mg/day), but in vitro antifungal susceptibility demonstrated high resistant to this and another six antifungals, with exception to terbinafine. The lesions did not regress with itraconazole treatment. Thus, 500 mg/day of terbinafine was prescribed and clinical cure was obtained after four months
机译:我们报告了一例右上肢淋巴皮孢子体病患者。通过钙调蛋白基因测序将该真菌鉴定为严格的Sporothrix schenckii senso stricto。最初的治疗是伊曲康唑(200 mg /天),但体外抗真菌药性对此药和另外6种抗真菌药表现出高耐药性,特比萘芬除外。伊曲康唑治疗未使病变消退。因此,处方了500毫克/天的特比萘芬,四个月后即可获得临床治愈

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号